Home » About Us » Clinical Trials » Amgen 20170542
Amgen 20170542
Research Title: A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration
Sponsor: Amgen
Principal Investigator: Atul Sharma, MD
Description: The purpose of this study is to compare the efficacy and safety of ABP 938 versus Aflibercept (Eylea®) in the treatment of neovascular age-related macular degeneration. Subjects will be randomized in a masked 1:1 ratio to receive 2 mg (0.05 mL) of either ABP 938 (Treatment Group A) or aflibercept (Treatment Group B) administered by intravitreal (IVT) injection.
Start Date: September 2020
Recruitment: Not Yet Recruiting
Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, CCRC; Stephanie Campbell, CRC; Amber Adams, CRC
Location(s): Marietta; 833 Campbell Hill Street, Suite 300, Marietta, GA 30060
Clinical Trial Team
Active Trials
- Amgen 20170542
- Apellis APL2-303 DERBY
- Gemini GEM-NH-001 Clarity 1
- Genentech GR40349 YOSEMITE
- Genentech GR40548 ARCHWAY
- Genentech GR40973 Gallego
- Gyroscope Therapeutics GTSCOPE
- Iveric Bio ISEE2008 GATHER2
- NGM Biopharmaceuticals NGM621-GA-201 CATALINA
- Novartis CRTH258A2303 TALON
- Novartis CRTH258B2305 Kingfisher
- Novartis CRTH258C2302 Raven
- Novo Nordisk NN9535-4352 FOCUS
- Regeneron VGFTe(HD)-DME-1934 PHOTON
- Roche GR40549 PORTAL
- Roche GR40550 PAGODA
- Roche GR40844 LUCERNE
- Roche GR41675 PAVILION
- Roche GR41987 RHONE-X
- SamChungDang SCD411-CP101
- Xbrane XBR1002 XPLORE
Past Trials
- AART C-02-60
- Acucela 4429-202 SEATTLE
- Aerpio AKB-9778-CI-5001 TIME-2b
- Allergan 150998-005 CEDAR
- Allergan 1771-201-008 MAPLE
- Allergan 190342-038 BEACON
- ALLERGAN 206207-012
- AREDS2
- AREDS2 ForeseeHome
- C-09-067 RACE
- DRCR.net Protocol N
- Gemini GEM-NH-002 Clarity 2
- Genentech GR39821
- Graybug GBV-102-002 Altissimo
- HORIZON FVF3426g
- KalVista KVD011-201
- LFG316A2203
- MARINA FVF2598g
- Novartis CSPP100A2244
- Ocriplasmin Research to Better Inform Treatment (ORBIT)
- OPH1002
- OPH1004
- Ophthotech OPH2003
- PDEX
- Regeneron R2176-3-AMD-1417 CAPELLA
- Regeneron R910-3-AMD-1517 ONYX
- Regeneron R910-3-DME-1518 RUBY
- Regeneron VGFTe-OD-1411 PANORAMA
- RIDE FVF4168g
- RISE FVF4170g
- Roche BP 30099 BOULEVARD
- Roche BP29647 AVENUE
- Roche GX29176 CHROMA
- Roche GX30191 OMASPECT
- SAILOR FVF3689g
- SCORE
- SCORE2
- Suprachoroidal Buckling for Retinal Detachment
- Taiwan Liposome Company (TLC) TLC399A2002
- Xcenda C-01-17 ForeseeHome